Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition
Mark B. Horton, OD, MD,1,* Christopher J. Brady, MD, MHS,2,* Jerry Cavallerano, OD, PhD,3,4 Michael Abramoff, MD, PhD,5,,6,,7,,8,,9,,10 Gail Barker, PhD, MBA,11 Michael F. Chiang, MD,12,,13 Charlene H. Crockett, MD,14 Seema Garg, MD, PhD,15 Peter Karth, MD, MBA,16 Yao Liu, MD, MS,17 Clark D. Newman, OD,18 Siddarth Rathi, MD, MBA,19 Veeral Sheth, MD, MBA,20 Paolo Silva, MD,3,4 Kristen Stebbins, MSPH,21 and Ingrid Zimmer-Galler, MD22
The following document and appendices represent the third edition of the Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy. These guidelines were developed by the Diabetic Retinopathy Telehealth Practice Guidelines Working Group. This working group consisted of a large number of subject matter experts in clinical applications for telehealth in ophthalmology.
The American Telemedicine Association (ATA) brings together diverse groups from traditional medicine, academia, technology, telecommunications companies, e-health, allied professional and nursing associations, medical associations, government, military, regulatory, and other stakeholders to address and advance compliance with legal, ethical, and professional standards in the practice of telemedicine. The ATA has embarked on an organized effort to establish guidelines for the practice of telemedicine in various clinical applications to define patient and provider expectations, aspire to uniform quality of service for patients and providers, enhance patient experience, and enable providers to deliver appropriate care using evidence-based practices.